Home > Boards > US OTC > Biotechs > International Stem Cell Corp. (ISCO)

Phase I of the clinical study is almost

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Doctor_Hari_Seldon Member Profile
 
Followed By 9
Posts 830
Boards Moderated 0
Alias Born 10/19/08
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 2:56:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 1:48:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2019 1:47:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:05:35 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:31:48 AM
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial InvestorsHub NewsWire - 4/29/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:33:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2019 2:13:50 PM
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results InvestorsHub NewsWire - 4/16/2019 8:30:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2019 6:13:56 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/1/2019 4:32:13 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/7/2019 6:05:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:42:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:42:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 4:41:47 PM
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury InvestorsHub NewsWire - 2/13/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2019 4:27:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/22/2019 6:16:40 PM
International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business InvestorsHub NewsWire - 1/15/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/6/2018 8:04:03 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/6/2018 8:01:22 AM
International Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment Research InvestorsHub NewsWire - 12/5/2018 8:30:00 AM
International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018 InvestorsHub NewsWire - 11/15/2018 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2018 6:07:57 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 5:01:04 PM
Doctor_Hari_Seldon   Sunday, 10/14/18 02:25:48 PM
Re: None
Post # of 6548 
Phase I of the clinical study is almost complete. No problems have been noted in this dose escalation safety and preliminary efficacy study of ISC-hpNSC®, intracranially transplanted patients with moderate Parkinson's disease. Phase II appears to be a certainty. This should be good for the stock, but more importantly for those suffering with Parkinsons and TBI (Traumatic Brain Injury, which the science is applicable to) lets hope for even moderate success. Any improvement, even if only to enhance and allow other treatments to be effective, is a big plus for any patient suffering from these debilitating neurological issues. I look forward to reading interim and long term results and to seeing Phase II studies underway. In the biotech world, few seldom take notice until Phase II studies are indeed underway.

Science, for the betterment and improvement in the life of humankind and all that exist on this strange planet of ours. That pale blue dot, called home.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist